Figure 4

The graph displays a trend (test for trend of survivor function; p = 0.05) toward higher probability of stopping benzimidazole (i.e. albendazole) therapy over time in patients with lower SUVratio (i.e., median SUVratio in the first, second and third tertile were 1.23, 2.01 and 3.03).